SPECTRAL AI, INC. Selling and Marketing Expense
SPECTRAL AI, INC. (MDAI) reported Selling and Marketing Expense of $653.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-11
- SPECTRAL AI, INC. selling and marketing expense for the quarter ending 2026-06-30 was $653.00K, a 92.06% increase year-over-year.
- SPECTRAL AI, INC. selling and marketing expense for the quarter ending 2025-06-30 was $340.00K.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month |
|---|---|---|
| 2026-06-30 | $653.00K 10-Q · filed 2026-08-11 | $861.00K 10-Q · filed 2026-08-11 |
| 2025-06-30 | $340.00K 10-Q · filed 2026-08-11 | $646.00K 10-Q · filed 2026-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |